Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials
From MaRDI portal
Publication:5438331
DOI10.1080/03610920701386810zbMATH Open1187.62175OpenAlexW2148879979MaRDI QIDQ5438331FDOQ5438331
Authors: Jun Liu, Weili He, Hui Quan
Publication date: 23 January 2008
Published in: Communications in Statistics: Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610920701386810
Recommendations
- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
- Adaptive clinical trial designs for phase I cancer studies
- A new look at evaluating MTD designs in cancer research
- The adaptive accelerated biased coin design for phase I clinical trials
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Cites Work
Cited In (4)
- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
- The adaptive accelerated biased coin design for phase I clinical trials
- Adaptive clinical trial designs for phase I cancer studies
- Review of Statistical Treatment for Oncology Dose-Escalation Trial with Prolonged Evaluation Window or Fast Enrollment
This page was built for publication: Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5438331)